Related Experiment Videos
A new ambulatory system for extended esophageal pH monitoring
Insights
A new 24-hour ambulatory esophageal pH monitoring system (AMBI 24) safely and effectively evaluates pediatric gastroesophageal reflux (GER). This mobile system provides reliable data for medical management in children, including those with special needs.
Area of Science:
- Pediatric Gastroenterology
- Medical Device Evaluation
- Diagnostic Technology
Background:
- Gastroesophageal reflux (GER) is a common condition in infants and children.
- Accurate diagnosis of GER is crucial for effective management.
- Existing monitoring methods may limit patient mobility and comfort.
Purpose of the Study:
- To evaluate the safety and efficacy of a new 24-hour ambulatory esophageal pH monitoring system (AMBI 24) in pediatric patients.
- To assess the system's usability across a diverse pediatric population, including infants and children with psychomotor delay.
- To determine if the AMBI 24 system provides data comparable to standard monitoring equipment.
Main Methods:
- A cohort of 72 pediatric patients with suspected GER underwent 24-hour ambulatory esophageal pH monitoring using the AMBI 24 system.
- Monitoring was conducted both at home (n=47) and in a hospital setting (n=25).
- The system's performance was assessed for complications and patient tolerance across different age groups and developmental statuses.
Main Results:
- The AMBI 24 system was used without complications in all pediatric age groups, including infants and children with severe psychomotor delay.
- Data obtained from the AMBI 24 system were consistent with findings from standard esophageal pH monitoring equipment.
- The system facilitated patient mobility, allowing for monitoring in a home environment.
Conclusions:
- The 24-hour ambulatory esophageal pH monitoring system (AMBI 24) is a safe and effective tool for evaluating GER in pediatric patients.
- The system's ability to allow patient mobility enhances its utility in diagnosing GER.
- AMBI 24 provides reliable data that can guide subsequent medical management decisions for pediatric GER.
Abstract:
A new 24-h ambulatory esophageal pH monitoring system (AMBI 24) was evaluated in 72 pediatric patients with suspected gastroesophageal reflux (GER). Forty-seven of these patients were monitored at home and the other 25 in our hospital. This system was employed without complication in infants and a full range of pediatric patients, as well as in older children with severe psychomotor delay. The data obtained were consistent with those reported utilizing standard monitoring equipment, and the results served as the basis for subsequent medical management. The results of this study, therefore, suggest that this method of esophageal pH monitoring is a safe and effective means of evaluating GER while allowing for patient mobility.